Skip to Content

Allopurinol Injection

Last Updated: December 2, 2014
Status: Resolved

Products Affected - Description

Allopurinol injection, West-Ward (formerly Bedford product)
500 mg vial (NDC 55390-0106-01)    

Reason for the Shortage

West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired several products from Bedford Laboratories in July 2014 including allopurinol injection. West-Ward is not actively marketing allopurinol injection at this time.

Available Products

Aloprim injection, Mylan Institutional
500 mg vial (NDC 67457-0187-50)

Estimated Resupply Dates

Mylan Institutional has been supplying the market for several months.

Related Shortages

Updated

December 2, 2014; September 3, 2014; June 2, 2014; March 4, 2014; December 16, 2013; October 21, 2013; September 18, 2013; July 18, 2013; June 12, 2013; May 3, 2013; March 5, 2013, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide